On the political front, Robert F. Kennedy Jr. will become the next HHS secretary after he attained a majority of Senate votes ...

Novartis has agreed to buy Anthos from private equity firm Blackstone for $3.1 billion, taking Factor XI inhibitor abelacimab back in-house.

From consumer to healthcare, here's a list of key deals reported this week: Papa John's (NASDAQ:PZZA) jumped 18% on a report that a Qatari-backed investor is considering a takeover of the pizza chain.

Blackstone (BX) intends to offload its First Eagle business for at least $4B, the Financial Times reports. The move comes as private equity ...

Blackstone (NYSE:BX) and Corsair Capital are looking to sell First Eagle Investment Management for more than $4B, the Financial Times reported late Friday, citing people briefed on the matter.

Novartis has claimed accelerated approval from the FDA for a second indication for Fabhalta – IgA nephropathy (IgAN) – as it charts a course to blockbuster sales for the drug. The US regulator ...

Explore opportunities with Novartis and Sandoz below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.